GFL Rating Confirmed AA+/Stable by CRISIL on Strong Performance, EV Capex

CHEMICALS
Whalesbook Corporate News Logo
AuthorVihaan Mehta|Published at:
GFL Rating Confirmed AA+/Stable by CRISIL on Strong Performance, EV Capex
Overview

CRISIL Ratings has reaffirmed Gujarat Fluorochemicals Limited's (GFL) long-term rating at AA+/Stable and short-term rating at A1+. The stable outlook is supported by GFL's consistent strong operating performance in the first nine months of FY26, showing revenue growth and better margins. The rating also reflects GFL's major planned capital spending in new fluoropolymer areas, especially for EV battery chemicals. GFL's strong market standing and integrated operations remain key strengths.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

CRISIL Ratings has confirmed Gujarat Fluorochemicals Limited's (GFL) long-term rating at CRISIL AA+/Stable and its short-term rating at CRISIL A1+. The agency also withdrew its rating on Rs. 50 crore of Non-Convertible Debentures upon their maturity. This confirmation signals continued confidence in GFL's financial stability and operational capabilities.

Ratings Confirmed on Strong Performance and Growth Plans
The stable ratings are crucial as they ensure GFL can continue accessing credit markets on favorable terms. This access is vital for funding the company's significant growth plans, particularly in high-potential sectors like EV chemicals. The reaffirmed rating offers a positive signal to investors regarding GFL's creditworthiness and future outlook.

Key Performance Indicators and Strategic Investments
Gujarat Fluorochemicals, a leading player in India's fluorine chemistry sector, has consistently maintained strong ratings. While FY24 performance saw a dip due to market shifts and inventory adjustments in fluoropolymers, CRISIL noted a strong recovery in FY25 and the first nine months of FY26. This rebound was driven by improved operating efficiency and recovering demand, especially in fluoropolymers. Strategically, GFL plans annual capital expenditure of around ₹1,700 crore, focusing on new fluoropolymer segments like EV battery chemicals. Recent performance in Q3 FY26 showed mixed results, with fluorochemicals facing challenges while fluoropolymers remained strong. GFL is also addressing a customs demand order from October 2024, which it is contesting and expects to have no significant financial impact.

Credit Implications and Market View
Favorable credit access will continue for GFL's debt-funded growth initiatives. Market confidence in GFL's financial strength and operational ability is reinforced. The company's aggressive expansion plans in areas like EV chemicals receive support, potentially strengthening investor sentiment due to rating stability.

Potential Risks and Challenges
International chemical market volatility, including global supply/price changes and new overseas capacity, poses a risk. Geopolitical factors like US tariffs and production quotas could impact performance. A slower-than-expected ramp-up of new fluoropolymer segments or reliance on debt for expansion could pressure financial metrics. Currency exchange rate fluctuations present an ongoing risk. The ongoing customs demand, even if the company expects no material impact, remains a regulatory matter.

Competitive Landscape
Gujarat Fluorochemicals competes with players like SRF Limited and Navin Fluorine International in the specialty chemicals market. These competitors are also expanding their capacities and product portfolios in high-value chemical segments, highlighting the competitive nature of the industry.

Financial Snapshot
Key financials for the nine months ended March 31, 2026 (9M FY26):

  • Revenue from operations: ₹3,628 crore
  • Operating Margin: 27%
  • Net Debt: Approximately ₹1,532 crore (as of December 31, 2025)

What to Watch
Investors will monitor the commercialization progress for new fluoropolymer products, especially EV battery chemicals, expected from the second half of FY27. Sustained recovery and stability of operating margins, targeted in the 25-27% range over the medium term, and improvement in Return on Capital Employed (RoCE) as new segments contribute, are key. Any significant debt-funded expansion or acquisitions that could impact the company's financial risk profile, along with the resolution of ongoing geopolitical and trade-related uncertainties, will also be important.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.